IKARIAN CAPITAL, LLC – Rigel Pharmaceuticals, Inc. Transaction History
IKARIAN CAPITAL, LLC portfolio value:
$0
portfolio value
IKARIAN CAPITAL, LLC quarter portfolio value change:
+4.42%
quarter
Rigel Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -100.00% | -702.77K shares | -794K | $1.18 | 0 |
Q2 2022 | share | Decrease | -67.12% | -1.43M shares | -5.59M | $1.13 | 702.77K |
Q1 2022 | share | Increase | +386.42% | 1.69M shares | 5.22M | $2.99 | 2.13M |
Q4 2021 | share | Increase | 0.00% | 439.35K shares | 1.16M | $2.68 | 439.35K |
Q1 2021 | share | Decrease | -100.00% | -345.52K shares | -1.20M | $3.42 | 0 |
Q4 2020 | share | Decrease | -50.32% | -350K shares | -459K | $3.5 | 345.52K |
Q3 2020 | share | Decrease | -58.61% | -985K shares | -1.40M | $2.4 | 695.52K |
Q2 2020 | share | 0.00% | 0 shares | 453K | $1.83 | 1.68M | |
Q1 2020 | share | Increase | +380.15% | 1.33M shares | 1.87M | $1.56 | 1.68M |
Q4 2019 | share | Increase | 0.00% | 350K shares | 749K | $2.14 | 350K |